About This Role
The mission of Biogen’s Biologics Drug Discovery group is to design, optimize, and develop high-quality differentiated protein therapeutics that become transformative medicines. This group is a part of the BTMS (Biotherapeutics and Medicinal Sciences) organization, Biogen’s modality unit. Using new technologies, cutting-edge science, and strong internal and external partnerships, we are leveraging our expertise in antibody discovery, protein and cell engineering, and biochemistry to transform the field of neuroscience.
Biogen is looking for an innovative and dedicated scientist to become the Director/Head of the Tissue-Enhanced Delivery Technologies group, who will lead direct reports as well as a cross-functional effort to identify and validate novel methods for enhancing delivery of biologics, oligonucleotides (including ASOs), and gene therapy modalities to tissues including muscle and brain.
More information is available in the full advertisement here.